Details and statistics on the import of unlicensed medicines from March 2014 onwards.
Similar Posts
Transparency data: Medicines and Healthcare products Regulatory Agency spending over £25,000: 2025 to 2026
Information on Medicines and Healthcare products Regulatory Agency spending over £25,000.
Keep the warmth, lose the risk: MHRA and National Fire Chiefs Council issue winter emollient safety warning
As colder weather arrives, the Medicines and Healthcare products Regulatory Agency (MHRA) and the National Fire Chiefs Council (NFCC) are urging the public to be aware of fire risks linked to emollient skin creams.
MHRA Safety Roundup: January 2026
Summary of the latest safety advice for medicines and medical device users
Variations to marketing authorisations (MAs)
How the MHRA processes variations to marketing authorisations.
MHRA approves UK’s first anti-PD-1 monoclonal antibody for treatment of aggressive form of lung cancer
As with all products, we will keep its safety under close review
Vorasidenib approved to treat patients 12 years and older with grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 16th September 2025, approved the medicine vorasidenib (Voranigo).